Neurobiology of rare diseases - Neurobiologia de malalties minoritàries (NEURADIS)
2021 SGR 00323
![Foto de Neurobiology of rare diseases - Neurobiologia de malalties minoritàries (NEURADIS)](/img/grupo.png)
![Foto de Hospital Universitario Arnau de Vilanova](/img/noimage_org.png)
Hospital Universitario Arnau de Vilanova
Lleida, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (4)
2023
-
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118
2016
-
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371
2011
-
The canonical nuclear factor-κB pathway regulates cell survival in a developmental model of spinal cord motoneurons
Journal of Neuroscience, Vol. 31, Núm. 17, pp. 6493-6503
2008
-
Neuroprotection by neurotrophic factors and membrane depolarization is regulated by calmodulin kinase IV
Journal of Biological Chemistry, Vol. 283, Núm. 7, pp. 4133-4144